Disclosure 0001213900-26-103540-1

SEC FORM 4

—

ORAMED PHARMACEUTICALS INC. (ORMP)

Acquisition (code A) of 349,497 shares; price not stated (see filing).

Reporting Person KIDRON NADAV · Officer Title President and CEO · Transaction Code A

Traded Sep 24, 2026 · Disclosed Sep 25, 2026

Source: SEC Form 4 · 0001213900-26-103540 · filed 2026-09-25 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "ORAMED PHARMACEUTICALS INC. (ORMP)." Disclosed 2026-09-25. https://desqlong.com/cards/0001213900-26-103540-1 (retrieved 2026-09-26).